Cammarota, Antonella http://orcid.org/0000-0001-9967-4694
D’Alessio, Antonio http://orcid.org/0000-0002-9164-3671
Pressiani, Tiziana http://orcid.org/0000-0001-6919-1536
Rimassa, Lorenza http://orcid.org/0000-0001-9957-3615
Personeni, Nicola http://orcid.org/0000-0002-7995-272X
Article History
Accepted: 22 May 2021
First Online: 21 June 2021
Declarations
:
: No sources of funding were used to conduct this study or prepare this manuscript. No writing assistance was utilized in the production of this manuscript.
: Tiziana Pressiani received consulting fees from Bayer, as well as institutional research funding from Bayer, Lilly, and Roche. Lorenza Rimassa received consulting fees from Amgen, ArQule, AstraZeneca, Basilea, Bayer, BMS, Celgene, Eisai, Exelixis, Genenta, Hengrui, Incyte, Ipsen, IQVIA, Lilly, MSD, Nerviano Medical Sciences, Roche, Sanofi, and Zymeworks; lecture fees from AbbVie, Amgen, Bayer, Eisai, Gilead, Incyte, Ipsen, Lilly, Merck Serono, Roche, and Sanofi; travel expenses from Ipsen; and institutional research funding from Agios, ARMO BioSciences, AstraZeneca, BeiGene, Eisai, Exelixis, Fibrogen, Incyte, Ipsen, Lilly, MSD, Nerviano Medical Sciences, Roche, and Zymeworks. Nicola Personeni received consulting fees from Amgen, Merck Serono, and Servier; lectures fees from AbbVie, Gilead, Lilly, and Sanofi; travel expenses from Amgen, and ArQule; and institutional research funding from Basilea, Merck Serono, and Servier. All authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed equally to the contents of this article and to editorial decisions.